Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
GnIH: Bloodwork Guide
Recommended lab tests and biomarkers to monitor before, during, and after GnIH therapy. Testing schedules are based on clinical protocols and published monitoring guidelines.
Back to GnIH overviewDuring Treatment (3 tests)
| Biomarker | Expected Effect | Retest |
|---|---|---|
| Luteinizing Hormone | ↓ decreases | Every 4 weeks |
| Follicle-Stimulating Hormone | ↓ decreases | Every 4 weeks |
| Testosterone | ↓ decreases | Every 8 weeks |